Understanding Cancer
Oncology is a rapidly evolving field. Cancer is fundamentally a disease of cellular regulation, where genetic mutations allow cells to proliferate unchecked. At our clinic in Peshawar, we utilize molecular insights to provide targeted care.
Clinical Note
"Early diagnosis is not just a goal; it's a therapeutic necessity. Modern oncology has shifted from a one-size-fits-all approach to precision medicine tailored to the individual's genetic profile."
Pathologies & Common Types
We manage a wide spectrum of oncological pathologies using international protocols (NCCN/ESMO). Each case is reviewed for molecular markers to ensure precision treatment.
Breast Pathology
Comprehensive management including hormonal therapy, targeted HER2 treatment, and specialized chemotherapy for all stages.
Thoracic Oncology
Focusing on Small Cell and Non-Small Cell Lung Cancer with emphasis on EGFR, ALK, and ROS1 mutation profiling.
Gastrointestinal
Advanced treatment for Colorectal, Pancreatic, Gastric, and Esophageal cancers using modern multi-agent regimens.
Hematological
Expert management of Leukemias (AML/CML), Lymphomas (Hodgkin & Non-Hodgkin), and Multiple Myeloma.
Gynecological
Specialized care for Ovarian, Cervical, and Endometrial cancers, focusing on surgical coordination and systemic therapy.
Urological
Treatment of Prostate, Bladder, and Renal (Kidney) cell carcinomas using hormonal and immunotherapy approaches.
Head & Neck
Management of Squamous cell carcinomas of the oral cavity, larynx, and pharynx with a multidisciplinary approach.
Sarcomas
Highly specialized treatment for Soft Tissue and Bone sarcomas (Osteosarcoma, Ewing Sarcoma) across all age groups.
Neuro-Oncology
Comprehensive care for primary brain tumors (Glioblastoma) and central nervous system metastases.
Dermatological
Advanced treatment for Melanoma, Basal Cell, and Squamous Cell carcinomas using immunotherapy and targeted agents.
Endocrine
Management of Thyroid cancers and Neuroendocrine tumors (NETs) focusing on specialized systemic interventions.
Therapeutic Options
Our treatment strategies are evidence-based and multidisciplinary.
Systemic Chemotherapy
Utilizing cytotoxic agents to eliminate rapidly dividing cells. We focus on optimizing dose intensity while minimizing toxicity.
Immunotherapy (Checkpoint Inhibitors)
Leveraging the body's immune system (PD-1/PD-L1 inhibitors) to recognize and destroy malignant cells.
Molecular Targeted Therapy
Small molecule inhibitors and monoclonal antibodies that interfere with specific pathways required for tumor growth.
Pathway to Recovery
The patient journey is a structured process designed for clinical excellence.
- Initial Consultation: Comprehensive history and physical examination.
- Diagnostics: Radiographic (CT/PET) and Pathological (Biopsy/IHC) confirmation.
- Staging: Utilizing TNM classification to determine disease extent.
- Tumor Board Review: Multidisciplinary discussion for optimal planning.
- Treatment Phase: Active therapy with regular monitoring of markers and imaging.
- Survivorship: Long-term follow-up and recurrence monitoring.
Clinical Support & Side Effects
Supportive oncology is critical for maintaining treatment adherence and quality of life.
Management Strategy
We utilize pro-active anti-emetic protocols and growth factor support (G-CSF) to manage neutropenia and ensure patient safety throughout the cycle.
Nutrition & Lifestyle
Nutritional status is a prognostic factor in oncology. We emphasize a high-protein, calorie-adequate diet to prevent cachexia.
Patient FAQs
Common questions addressed by our clinical team to help you navigate your treatment journey.
Plans are based on the type of cancer, stage, genetic markers (like HER2, EGFR), and the patient's overall performance status (ECOG/Karnofsky scores). We follow international NCCN and ESMO guidelines.
Not all chemotherapy causes hair loss. It depends on the specific drugs used. Your oncologist will discuss the likelihood of alopecia and management options like cold caps or cranial prostheses.
Many patients continue to work, sometimes with a modified schedule. It depends on the type of treatment and how your body responds. We can provide medical documentation for workplace accommodations.
A second opinion is a standard practice in oncology. It ensures that the diagnosis and treatment plan are robust. We welcome collaboration with other experts to ensure the best outcome for you.
Clinical trials offer access to cutting-edge treatments before they are widely available. We evaluate every patient's eligibility for relevant local or international trials.
PET-CT scans provide a metabolic map of the body, helping us identify active cancer cells and determine the exact stage of the disease more accurately than standard CT scans.
Fatigue is common but manageable through light physical activity, proper nutrition, and sometimes medical intervention. Resting too much can actually worsen fatigue in some cases.
Costs vary depending on the therapy (e.g., immunotherapy is typically more costly than standard chemo). We work with patients to find the most effective treatment within their financial considerations.
Immunotherapy uses the body's own immune system to fight cancer. It has revolutionized the treatment of melanoma, lung cancer, and renal cancers with fewer side effects than traditional chemo.
Travel is often possible between cycles, provided your blood counts (ANC) are stable. Always consult your oncologist before planning any significant travel.
A high-protein, calorie-sufficient diet helps prevent muscle loss (cachexia) and supports the immune system. We often recommend working with an oncology nutritionist.
No, cancer is not contagious. It cannot be spread from person to person through contact or proximity.
Survivorship care focuses on life after cancer, including long-term monitoring for recurrence and managing any late-onset side effects of treatment.
Some herbal supplements can interfere with chemotherapy drugs, reducing their effectiveness or increasing toxicity. Always inform your oncologist about any supplements you are taking.
We monitor progress through physical exams, blood tumor markers (like CEA, PSA, CA-125), and periodic imaging (CT, MRI, or PET-CT).